Research
Babizhayev et al1 discussed that this ophthalmic drug had high potential for the non-surgical treatment of age-related cataracts in canines and has been shown to have high efficacy and good tolerability. Thirty dogs were allocated the topical application of the drug in eye-drops twice daily to cure cataracts, and a control group consisted of 15 dogs that received placebo eyedrops and 10 dogs that received no eye-drops. The animal eyes were evaluated at entry and followed up every 2 months for a 6 month period. Cataract was measured using slit-images and retro-illumination examination of the lens. After 6 months 96% of eyes treated with the drug showed improvements in the slit-image and retro-illumination examination of the lens.
|
Canine cataract before treatment
|
|
After 2 weeks of treatment
|
|
After 1 month of treatment, with the breakup of the impaired proteins already becoming visible, known as 'the melting snow' effect. The lens becomes clearer.
|
The CatCure drops themselves contain the N-acetylcarnosine compound. Application
of N-acetylcarnosine eyedrops appears to be a safe, effective means to prevent cataracts, and possibly to treat emerging cataracts.
The high costs of the surgical procedure to remove cataracts, the limited numbers of trained surgeons, the potential risk of surgical complications, and the simple fact that an artificial lens does not have the optical qualities of a natural lens, make a nonsurgical procedure such as the use of CatCure a very attractive proposition.
Please note that while the published references support the use of N-acetylcarnosine based drops as an effective solution in improving vision in animals, the use of these references and any product names does not imply endorsement or guarantee of improvement of vision.
|
